Rxo (RXO) Net Margin (2021 - 2025)
Historic Net Margin for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to 3.13%.
- Rxo's Net Margin fell 16300.0% to 3.13% in Q4 2025 from the same period last year, while for Dec 2025 it was 1.74%, marking a year-over-year increase of 46300.0%. This contributed to the annual value of 1.74% for FY2025, which is 46300.0% up from last year.
- Per Rxo's latest filing, its Net Margin stood at 3.13% for Q4 2025, which was down 16300.0% from 0.99% recorded in Q3 2025.
- In the past 5 years, Rxo's Net Margin registered a high of 3.59% during Q2 2022, and its lowest value of 23.37% during Q3 2024.
- For the 5-year period, Rxo's Net Margin averaged around 1.21%, with its median value being 0.36% (2022).
- Its Net Margin has fluctuated over the past 5 years, first crashed by -232600bps in 2024, then soared by 223800bps in 2025.
- Over the past 5 years, Rxo's Net Margin (Quarter) stood at 3.17% in 2021, then crashed by -111bps to 0.36% in 2022, then skyrocketed by 157bps to 0.2% in 2023, then crashed by -833bps to 1.5% in 2024, then tumbled by -109bps to 3.13% in 2025.
- Its Net Margin was 3.13% in Q4 2025, compared to 0.99% in Q3 2025 and 0.63% in Q2 2025.